Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wicker

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes modelKritika Kachapati, David E Adams, Yuehong Wu, et al.
Wellcome Open Research|May 14, 2020
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trialM Loredana Marcovecchio, Linda S Wicker, David B Dunger, et al.
Diabetes|January 24, 2003
NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance inductionTodd Pearson, Thomas G Markees, Linda S Wicker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance allelesXavier Martinez, Huub T C Kreuwel, William L Redmond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1P L Podolin, P Denny, C J Lord, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Genetics|May 3, 2001
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetesH J Cordell, J A Todd, N J Hill, et al.
Journal of Cheminformatics|February 6, 2024
AdductHunter: identifying protein-metal complex adducts in mass spectraDerek Long, Liam Eade, Matthew P Sullivan, et al.
Database : the Journal of Biological Databases and Curation|June 5, 2013
The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetesCharles A Steward, Jose M Gonzalez, Steve Trevanion, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|October 16, 2012
The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes modelKritika Kachapati, David E Adams, Yuehong Wu, et al.
Wellcome Open Research|May 14, 2020
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trialM Loredana Marcovecchio, Linda S Wicker, David B Dunger, et al.
Diabetes|January 24, 2003
NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance inductionTodd Pearson, Thomas G Markees, Linda S Wicker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance allelesXavier Martinez, Huub T C Kreuwel, William L Redmond, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1997
Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1P L Podolin, P Denny, C J Lord, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligandsA B Jones, J J Acton, A D Adams, et al.
Genetics|May 3, 2001
Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetesH J Cordell, J A Todd, N J Hill, et al.
Journal of Cheminformatics|February 6, 2024
AdductHunter: identifying protein-metal complex adducts in mass spectraDerek Long, Liam Eade, Matthew P Sullivan, et al.
Database : the Journal of Biological Databases and Curation|June 5, 2013
The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetesCharles A Steward, Jose M Gonzalez, Steve Trevanion, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Pageof 24